Omiganan clinical trials
How each study uses Omiganan is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
Studies by the year they started
7 studies that test it; most in 2017 (2)
| Year | Studies |
|---|---|
| 2005 | 1 |
| 2008 | 1 |
| 2013 | 1 |
| 2015 | 1 |
| 2017 | 2 |
| 2018 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 7 · Other 0
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses Omiganan is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 7
- Study to Evaluate the Long-term Safety of a Once-Daily Omiganan Topical GelCompletedPhase 3Maruho Co., Ltd.NCT02576847Written as OmigananHow we know
- Omiganan Twice a Day (BID) in Patients With Facial Seborrheic DermatitisStatus unknownPhase 2Maruho Co., Ltd.NCT03688971Written as OmigananHow we know
- Pharmacodynamics of Omiganan BID in Patients With Atopic DermatitisCompletedPhase 2Maruho Co., Ltd.NCT03091426Written as OmigananHow we know
- Topical Challenge With Omiganan and Imiquimod in Healthy VolunteersCompletedPhase 1Maruho Co., Ltd.NCT03071679Written as OmigananHow we know
- A Twelve Week Safety and Efficacy Study in RosaceaCompletedPhase 2Maruho Co., Ltd.NCT01784133Written as omigananHow we know
- Study of Antimicrobial Activity of Omiganan 1% Gel vs. Chlorhexidine 2% for Topical Skin Antisepsis in Healthy Adult SubjectsCompletedPhase 3Cadence PharmaceuticalsNCT00608959Written as omiganan 1% gelHow we know
- Study of Omiganan 1% Gel in Preventing Catheter Infections/Colonization in Patients With Central Venous CathetersCompletedPhase 3Cadence PharmaceuticalsNCT00231153Written as Omiganan 1% gelHow we know
Codes
What other systems call Omiganan · ClinicalTrials.gg INT000868
- UNII (FDA) 618SLL9VBSOMIGANANConfirmed FDA, Wikidata
- Wikidata Q27263320omigananConfirmed FDA, Wikidata
- NCI Thesaurus C166886OmigananOne source FDA
- DrugBank DB06610One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | 618SLL9VBS | OMIGANAN | Confirmed FDA, Wikidata |
| Wikidata | Q27263320 | omiganan | Confirmed FDA, Wikidata |
| NCI Thesaurus | C166886 | Omiganan | One source FDA |
| DrugBank | DB06610 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.